Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marinaro

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxinM Marinaro, P N Boyaka, R J Jackson, et al.
Headache|July 17, 1998
Cytokines and migraine: increase of IL-5 and IL-4 plasma levelsI Munno, V Centonze, M Marinaro, et al.
Immunopharmacology and Immunotoxicology|January 1, 1992
On the physiological significance of tumor necrosis factor-alpha in the human amniotic fluidV Covelli, M Jaccarino, F Massari, et al.
The American Journal of Clinical Nutrition|March 10, 2001
High prevalence of lactose absorbers in Northern Sardinian patients with type 1 and type 2 diabetes mellitusG F Meloni, C Colombo, C La Vecchia, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
Journal of Biotechnology|January 26, 1996
Mucosal immunity: regulation by helper T cells and a novel method for detectionR J Jackson, M Marinaro, J L VanCott, et al.
Annals of the New York Academy of Sciences|February 13, 1996
The role of Th1 and Th2 cells for mucosal IgA responsesM Yamamoto, J L Vancott, N Okahashi, et al.
The Journal of Infectious Diseases|March 1, 1996
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxinI Takahashi, M Marinaro, H Kiyono, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunityP N Boyaka, M Marinaro, R J Jackson, et al.
The American Journal of Tropical Medicine and Hygiene|May 27, 1999
Strategies for mucosal vaccine developmentP N Boyaka, M Marinaro, J L Vancott, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxinM Marinaro, P N Boyaka, R J Jackson, et al.
Headache|July 17, 1998
Cytokines and migraine: increase of IL-5 and IL-4 plasma levelsI Munno, V Centonze, M Marinaro, et al.
Immunopharmacology and Immunotoxicology|January 1, 1992
On the physiological significance of tumor necrosis factor-alpha in the human amniotic fluidV Covelli, M Jaccarino, F Massari, et al.
The American Journal of Clinical Nutrition|March 10, 2001
High prevalence of lactose absorbers in Northern Sardinian patients with type 1 and type 2 diabetes mellitusG F Meloni, C Colombo, C La Vecchia, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
Journal of Biotechnology|January 26, 1996
Mucosal immunity: regulation by helper T cells and a novel method for detectionR J Jackson, M Marinaro, J L VanCott, et al.
Annals of the New York Academy of Sciences|February 13, 1996
The role of Th1 and Th2 cells for mucosal IgA responsesM Yamamoto, J L Vancott, N Okahashi, et al.
The Journal of Infectious Diseases|March 1, 1996
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxinI Takahashi, M Marinaro, H Kiyono, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunityP N Boyaka, M Marinaro, R J Jackson, et al.
The American Journal of Tropical Medicine and Hygiene|May 27, 1999
Strategies for mucosal vaccine developmentP N Boyaka, M Marinaro, J L Vancott, et al.
Pageof 4